Free Access
Med Sci (Paris)
Volume 31, Number 3, Mars 2015
Page(s) 241 - 244
Section Nouvelles
Published online 08 April 2015
  1. Seymour JF, Presneill JJ. Pulmonary alveolar proteinosis: progress in the first 44 years. Am J Respir Crit Care Med 2002 ; 166 : 215–235. [CrossRef] [PubMed] [Google Scholar]
  2. Borie R, Danel C, Debray MP, et al. Pulmonary alveolar proteinosis. Eur Respir Rev 2011 ; 20 : 98–107. [CrossRef] [PubMed] [Google Scholar]
  3. Rosen LB, Freeman AF, Yang LM, et al. Anti-GM-CSF autoantibodies in patients with cryptococcal meningitis. J Immunol 2013 ; 190 : 3959–3966. [CrossRef] [PubMed] [Google Scholar]
  4. Whitsett JA, Wert SE, Weaver TE. Alveolar surfactant homeostasis and the pathogenesis of pulmonary disease. Annu Rev Med 2010 ; 61 : 105–119. [CrossRef] [PubMed] [Google Scholar]
  5. Stanley E, Lieschke GJ, Grail D, et al. Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology. Proc Natl Acad Sci USA 1994 ; 91 : 5592–5596. [CrossRef] [Google Scholar]
  6. Shibata Y, Berclaz PY, Chroneos ZC, et al. GM-CSF regulates alveolar macrophage differentiation and innate immunity in the lung through PU.1. Immunity 2001 ; 15 : 557–567. [CrossRef] [PubMed] [Google Scholar]
  7. Suzuki T, Sakagami T, Young LR, et al. Hereditary pulmonary alveolar proteinosis: pathogenesis, presentation, diagnosis, and therapy. Am J Respir Crit Care Med 2010 ; 182 : 1292–1304. [CrossRef] [PubMed] [Google Scholar]
  8. Greenhill SR, Kotton DN. Pulmonary alveolar proteinosis: a bench-to-bedside story of granulocyte-macrophage colony-stimulating factor dysfunction. Chest 2009 ; 136 : 571–577. [CrossRef] [PubMed] [Google Scholar]
  9. Uchida K, Beck DC, Yamamoto T, et al. GM-CSF autoantibodies and neutrophil dysfunction in pulmonary alveolar proteinosis. N Engl J Med 2007 ; 356 : 567–579. [CrossRef] [PubMed] [Google Scholar]
  10. Michaud G, Reddy C, Ernst A. Whole-lung lavage for pulmonary alveolar proteinosis. Chest 2009 ; 136 : 1678–1681. [CrossRef] [PubMed] [Google Scholar]
  11. Briens E, Delaval P, Mairesse MP, et al. La protéinose alvéolaire pulmonaire. Rev Mal Respir 2002 ; 19 : 166–182. [PubMed] [Google Scholar]
  12. Tazawa R, Inoue Y, Arai T, et al. Duration of benefit in patients with autoimmune pulmonary alveolar proteinosis after inhaled granulocyte-macrophage colony-stimulating factor therapy. Chest 2014 ; 145 : 729–737. [CrossRef] [PubMed] [Google Scholar]
  13. Kavuru MS, Malur A, Marshall A, et al. An open-label trial of rituximab therapy in pulmonary alveolar proteinosis. Eur Respir J 2011 ; 38 : 1361–1367. [CrossRef] [PubMed] [Google Scholar]
  14. Borie R, Debray V, Laine C, et al. Rituximab therapy in autoimmune pulmonary alveolar proteinosis. Eur Respir J 2009 ; 33 : 1503–1506. [CrossRef] [PubMed] [Google Scholar]
  15. Ishii H, Seymour JF, Tazawa R, et al. Secondary pulmonary alveolar proteinosis complicating myelodysplastic syndrome results in worsening of prognosis: a retrospective cohort study in Japan. BMC Pulm Med 2014 ; 14 : 37. [CrossRef] [PubMed] [Google Scholar]
  16. Ishii H, Nakata K, Inoue Y, et al. Clinical course of GM−CSF autoantibody negative pulmonary alveolar proteinosis (NAPAP): efficacy of lavage therapy. Am J Respir Crit Care Med 2009 ; 179 : A3035. [Google Scholar]
  17. Suzuki T, Sakagami T, Rubin BK, et al. Familial pulmonary alveolar proteinosis caused by mutations in CSF2RA. J Exp Med 2008 ; 205 : 2703–2710. [CrossRef] [PubMed] [Google Scholar]
  18. Martinez-Moczygemba M, Doan ML, Elidemir O, et al. Pulmonary alveolar proteinosis caused by deletion of the GM-CSFRalpha gene in the X chromosome pseudoautosomal region 1. J Exp Med 2008 ; 205 : 2711–2716. [CrossRef] [PubMed] [Google Scholar]
  19. Dirksen U, Nishinakamura R, Groneck P, et al. Human pulmonary alveolar proteinosis associated with a defect in GM-CSF/IL-3/IL-5 receptor common beta chain expression. J Clin Invest 1997 ; 100 : 2211–2217. [CrossRef] [PubMed] [Google Scholar]
  20. Hacein-Bey-Abina S, Pai SY, Gaspar HB, et al. A modified gamma-retrovirus vector for X-linked severe combined immunodeficiency. N Engl J Med 2014 ; 371 : 1407–1417. [CrossRef] [PubMed] [Google Scholar]
  21. Suzuki T, Arumugam P, Sakagami T, et al. Pulmonary macrophage transplantation therapy. Nature 2014 ; 514 : 450–454. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.